Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy
Open Access
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 124 (6) , 776-785
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Topical Nonsteroidal Anti-Inflammatory Drugs for Macular EdemaMediators of Inflammation, 2013
- Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathyClinical Ophthalmology, 2012
- Central Foveal Thickness Before and After Cataract Surgery in Normal and in Diabetic Patients without RetinopathyKlinische Monatsblätter für Augenheilkunde, 2012
- Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract SurgeryKorean Journal of Ophthalmology, 2011
- Postsurgical Cystoid Macular EdemaEuropean Journal of Ophthalmology, 2010
- Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular EdemaOphthalmology, 2007
- Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenacCurrent Medical Research and Opinion, 2006
- Macular edemaSurvey of Ophthalmology, 2004
- Cataract surgery and diabetic retinopathyCurrent Opinion in Ophthalmology, 1992
- Hyaluronate increases intraocular pressure when used in cataract extraction.British Journal of Ophthalmology, 1985